ONT-093 (OC 144093)
≥98%
- Product Code: 62527
CAS:
216227-54-2
| Molecular Weight: | 494.7 g./mol | Molecular Formula: | C₃₂H₃₈N₄O |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | -20°C, airtight, dry |
Product Description:
ONT-093, also known as OC 144093, is primarily recognized for its role as a potent inhibitor of P-glycoprotein (P-gp), a protein that plays a significant role in multidrug resistance (MDR) in cancer cells. By inhibiting P-gp, ONT-093 enhances the intracellular accumulation of chemotherapeutic agents, thereby increasing their efficacy in treating drug-resistant cancers. This makes it a valuable adjunct in combination therapies, particularly for cancers that have developed resistance to standard treatments.
In addition to its application in oncology, ONT-093 has been explored for its potential to improve the bioavailability of various drugs that are substrates of P-gp. This includes enhancing the absorption and distribution of drugs across the blood-brain barrier, which can be particularly beneficial for treating neurological disorders where drug delivery is often a challenge.
Research has also indicated that ONT-093 may have utility in reversing multidrug resistance in infectious diseases, particularly in cases where pathogens have developed resistance to antimicrobial agents. By inhibiting efflux pumps similar to P-gp in bacteria, ONT-093 can potentially restore the effectiveness of antibiotics that have become less potent due to resistance mechanisms.
Overall, ONT-093's ability to modulate drug transport mechanisms makes it a promising candidate for improving therapeutic outcomes in various fields, including cancer treatment, neurology, and infectious disease management.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.005 | 10-20 days | £1,625.37 |
+
-
|
ONT-093 (OC 144093)
ONT-093, also known as OC 144093, is primarily recognized for its role as a potent inhibitor of P-glycoprotein (P-gp), a protein that plays a significant role in multidrug resistance (MDR) in cancer cells. By inhibiting P-gp, ONT-093 enhances the intracellular accumulation of chemotherapeutic agents, thereby increasing their efficacy in treating drug-resistant cancers. This makes it a valuable adjunct in combination therapies, particularly for cancers that have developed resistance to standard treatments.
In addition to its application in oncology, ONT-093 has been explored for its potential to improve the bioavailability of various drugs that are substrates of P-gp. This includes enhancing the absorption and distribution of drugs across the blood-brain barrier, which can be particularly beneficial for treating neurological disorders where drug delivery is often a challenge.
Research has also indicated that ONT-093 may have utility in reversing multidrug resistance in infectious diseases, particularly in cases where pathogens have developed resistance to antimicrobial agents. By inhibiting efflux pumps similar to P-gp in bacteria, ONT-093 can potentially restore the effectiveness of antibiotics that have become less potent due to resistance mechanisms.
Overall, ONT-093's ability to modulate drug transport mechanisms makes it a promising candidate for improving therapeutic outcomes in various fields, including cancer treatment, neurology, and infectious disease management.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
£0.00
£0.00
Total :